ICI(11th international congress of immunology)
2001-07-08
org.kosen.entty.User@3b499bb9
김수기(sk302)
행사&학회소개
보고서작성신청
면역학학회중 제일 큰 국제회의로써 3년에 한번씩 열리는 대규모학회로 최상위급학회임. 금년에는 스웨덴, 스톡홀름에서 열리게 되는데 발표차 참석하게 되어 그 동향과 최신 정보를 나누고자 합니다.
때: July 22 - 27, 2001 장소 : The 11th International Congress of Immunology will take place at Stockholm International Fairs, Sunday July 22 - Friday July 27, 2001.
Around 600 internationally renowned immunologists are invited as speakers
or chairpersons in approximately 64 Symposia (S), 127 Workshops (W), 11
Current Controversies (C) and 10 State-of-the-Art / Educational Sessions (E).
Symposia (S)
Theme 1 Generation and lifespan of immunocompetent cells
S 1.1 Haematopoietic stem cell emergence, expansion and differentiation
S 1.2 Stem cell biology and transplantation
S 1.3 Lymphoid organogenesis
S 1.4 Lymphoid malignancies
S 1.5 Transcriptional control of lymphocyte differentiation
S 1.6 Molecular mechanisms of gene recombination in the immune system
S 1.7 Development of the innate immune system
S 1.8 Signalling in lymphocytes
S 1.9 Lymphocyte development
S 1.10 Genomic analysis of the evolution of the immune system
S 1.11 Physiology of the immune system
S 1.12 Apoptosis and the immune system
S 1.13 Central tolerance
S 1.14 Primary Immunodeficiencies
Theme 2 Induction of adaptive immunity
S 2.1 Dendritic cells in immune induction and regulation
S 2.2 Antigen processing and presentation in the MHC class I pathway
S 2.3 Antigen processing and presentation in the MHC class II pathway
S 2.4 Fc receptors in acquired immunity
S 2.5 The T cell receptor
S 2.6 Induction of B cells in germinal centers
S 2.7 The immunological synapse
S 2.8 Costimulation in health and disease
S 2.9 Molecular interactions in infection and immunity
S 2.10 Induction of memory
S 2.11 Effector functions
Theme 3 Regulation of the immune response
S 3.1 Regulatory cells and their microenvironment
S 3.2 Regulatory chemokines in the immune response
S 3.3 Lymphocyte trafficking
S 3.4 Central immunological tolerance
S 3.5 Genetics and effector mechanisms of autoimmunity
S 3.6 Allergy
S 3.7 Immunological diseases and their treatment
S 3.8 Interaction between tumours and the immune system
S 3.9 Regulatory mechanisms in immunity
S 3.10 Regulation of autoimmunity
S 3.11 Gene targeting in the immune system
S 3.12 Peripheral immunological tolerance
Theme 4 Host-parasite interactions, innate immunity,
reproductive and local immunity
S 4.1 Receptor activation of innate immune responses
S 4.2 Peptides and proteins as effector molecules in innate immunity
S 4.3 Microbial evasion of innate immunity
S 4.4 Antimicrobial activities of the innate immune system
S 4.5 Chemokines and chemokine receptors
S 4.6 Reproductive immunology
S 4.7 Links between innate and adaptive immunity
S 4.8 Acute and chronic inflammation of the gastrointestinal tract
S 4.9 Gene regulation of acute inflammation
S 4.10 Antigen processing and presentation at mucosal surfaces
S 4.11 Complement activation and regulation
S 4.12 NK cells in health and disease
S 4.13 Host-parasite interactions
S 4.14 Mechanisms of tolerance induction at mucosal sites
S 4.15 Effector mechanisms at mucosal tissues
Theme 5 Immunotherapy/ vaccination and immunomodulation in
autoimmunity, allergy, cancer and infectious diseases
S 5.1 Components of the ideal vaccine strategy
S 5.2 Novel approaches to vaccination
S 5.3 Specific vaccination targets
S 5.4 Peptides as tools for the treatment of immunological diseases
S 5.5 Use of antibodies/fragments in the treatment of human disease
S 5.6 Use of cytokines, cytokine receptors, chemokines in the
treatment of human disease
S 5.7 Cell transplantation
S 5.8 Genetic manipulation, drugs and drug design in the treatment
of immunological disease
S 5.9 Cancer/tumour immunology
S 5.10 Apoptosis as an immunotherapeutic tool in the treatment
of human disease
S 5.11 Immunotherapy in allergy
S 5.12 Organ transplantation
Workshops (W)
Theme 1 Generation and lifespan of immunocompetent cells
W 1.1 Stem cell and lymphoid progenitor differentiation
W 1.2 Characterisation of haematopoietic stem cells
W 1.3 Culture and expansion of human stem cells
W 1.4 Transcriptional control of lymphocyte differentiation
W 1.5 Lymphoid organogenesis
W 1.6 Lymphocyte development and lineage commitment
W 1.7 Rearrangement of antigen receptor genes
W 1.8 The B cell antigen receptor complex
W 1.9 The T cell antigen receptor complex
W 1.10 Evolution of antigen receptor genes
W 1.11 Selection of T cell repertoires
W 1.12 Selection of B cell repertoires
W 1.13 Extra-thymic T cell differentiation
W 1.14 Lymphocyte homeostasis and lifespans
W 1.15 Signalling through B and T cell receptors
W 1.16 Microdomains (rafts) in signalling
W 1.17 Downstream signalling in lymphocytes
W 1.18 Molecular mechanisms of apoptosis
W 1.19 Apoptosis in the physiology of the immune system
W 1.20 Lymphoid malignancies
W 1.21 Primary lymphoid immunodeficiencies
W 1.22 Primary non-lymphoid immunodeficiencies
W 1.23 Gene therapy for haematopoietic disease
W 1.24 Ageing of the immune system
Theme 2 Induction of adaptive immunity
W 2.1 Antigen processing (MHC class I mediated)
W 2.2 Antigen processing (MHC class II mediated)
W 2.3 Trafficking and assembly of MHC molecules
W 2.4 Specificity and predictions of peptide-MHC interactions
W 2.5 Structure of MHC class I and class II molecules
W 2 6 Structure and function of non-classical MHC molecules
W 2.7 Origin and migration of dendritic cells
W 2.8 Dendritic cells in antigen presentation and immune induction
W 2.9 Induction and maturation of antigen presenting cells
W 2.10 Interaction between APC and T cells
W 2.11 Activation of different T helper cell subsets
W 2.12 Three dimensional structure of immunological
receptor-ligand interactions
W 2.13 Role of Fc-receptors in induction of immunity
W 2.14 Regulatory molecules in B cell activation
W 2.15 Regulation of immunoglobulin class switch
W 2.16 Signal transduction through cytokine and chemokine receptors
W 2.17 T-B cell collaboration
W 2.18 Cytokines and cytokine receptors
W 2.19 Chemokines and chemokine receptors
W 2.20 CD4 T cell effector functions
W 2.21 CD8 T cell effector functions
W 2.22 Antibody isotypes and effector functions
W 2.23 Mechanisms of memory induction and maintenance
W 2.24 Superantigen-mediated activation of T cells
W 2.25 MHC polymorphism and its biological significance
Theme 3 Regulation of the immune response
W 3.1 Chemokines and cellular movements
W 3.2 Chemokines in clinical medicine
W 3.3 Leukocyte-endothelial cell interactions
W 3.4 Cell trafficking within lymphoid organs
W 3.5 Central tolerance and repertoire selection
W 3.6 Peripheral tolerance and the role of the APC
W 3.7 Immunogenetics of autoimmune diseases
W 3.8 Experimental autoimmune diseases
W 3.9 Generation of the atopic state
W 3.10 Immunotherapy of allergies
W 3.11 Cytokines as mediators of immunological diseases
W 3.12 Tumour escape from the immune system
W 3.13 Immunity to tumours
W 3.14 Dominant immunological suppression
W 3.15 Regulatory helper lymphocytes
W 3.16 Interleukins and lymphocyte activation
W 3.17 Autoimmunity in endocrine organs
W 3.18 Autoimmunity in the joint
W 3.19 Autoimmunity in the central nervous system
W 3.20 Peripheral immunological tolerance of self-reactive T
lymphocytes
W 3.21 B lymphocyte anergy
W 3.22 Apoptosis in peripheral immunological tolerance
W 3.23 Immunosuppressive drugs
Theme 4 Host-parasite interactions, innate immunity,
reproductive and local immunity
W 4.1 Receptors of innate immune responses
W 4.2 Cytokine regulation of innate immune responses
W 4.3 Anti-microbial peptides
W 4.4 Evolution of innate immune responses
W 4.5 Interface between innate and adaptive immunity
W 4.6 The role of g/d T cells and other non-classical T cells
in immune responses
W 4.7 Complement and collectins in the innate immune defence
W 4.8 The role of NK and NKT cells in immune effector mechanisms
W 4.9 Microbial evasion of immune responses
W 4.10 Mechanisms of protection against intracellular microorganisms
W 4.11 Nitric oxide (NO) and oxygen radicals in immune effector
mechanisms
W 4.12 Complement-, Fc- and collectin receptors
W 4.13 Chemokines and chemokine receptors in inflammation
W 4.14 Reproductive immunology
W 4.15 Inflammation of the gastrointestinal tract
W 4.16 The intestinal microbial flora in health and disease
W 4.17 Inflammation in the respiratory tract
W 4.18 Allergies of skin and mucosa
W 4.19 Gene therapy in inflammatory disorders
W 4.20 Induction of mucosal immune responses
W 4.21 Immunological disorders of the skinW 4.22 The role of
lamina propria T cells in health and disease
W 4.23 Complement activation and regulation in health and disease
W 4.24 Cytokines in infectious diseases
W 4.25 Mucosal mast cells, basophils and eosinophils in health and disease
W 4.26 Tolerance induced by mucosal exposure to antigen
W 4.27 Inflammation of connective tissue and blood vessels
W 4.28 Function and structure of TNF and lymphotoxin and their receptors
Theme 5 Immunotherapy/ vaccination and immunomodulation in autoimmunity,
allergy, cancer and infectious diseases
W 5.1 Target identification for vaccination and immunotherapy
W 5.2 Specific vaccination targets
W 5.3 Peptides as tools in the treatment of immunological disease
W 5.4 Antibodies/fragments as tools for the treatment of diseases
W 5.5 Cytokines and chemokines in the treatment of disease
W 5.6 Cell and stem cell transplantation
W 5.7 Genetic manipulation, drugs and drug design
W 5.8 Immunological treatment of tumours
W 5.9 Apoptosis as an immunotherapeutic tool
W 5.10 Organ transplantation
W 5.11 Cardiovascular inflammation and disease
W 5.12 Inflammatory diseases of the nervous system
W 5.13 Immunological aspects of neurodegenerative diseases
W 5.14 Immuno-endocrinology
W 5.15 Neuroimmunology (psychoneuroimmunology)
W 5.16 Immunological mechanisms in the treatment of rheumatic diseases
W 5.17 Immunological disorders in renal disease
W 5.18 Granulocytes in inflammation
W 5.19 Immunology of HIV
W 5.20 Immunology of malaria infections
W 5.21 Viral infections and viral immunity
W 5.22 Immunology of intracellular pathogens
W 5.23 Immunology of extracellular pathogens
W 5.24 Immunotechnology
W 5.25 Immunity to pathogens of the developing world
W 5.26 Microarray technologies
W 5.27 Novel approaches to vaccination
Current Controversies (C)
C 1 Industrial funding of academic research is a threat to scientific freedom
C 2 Vaccination against HIV is an impossible dream
C 3 Oral tolerance will be a solution in allergy and autoimmunity
C 4 MHC polymorphism is a consequence of microbial pressure
C 5 Activation of T cell immunity requires specific recognition of non-self
C 6 Xenotransplantation is a solution to organ shortage
C 7 Autoimmunity is a normal consequence of adequate immune reactivity
C 8 Immunological memory requires persistence of antigen
C 9 Immunological cancer therapy will have to be individualised
C 10 Experimental models are of limited value to understand autoimmune
diseases in man
C 11 Antigen-based immunotherapy in allergy is ineffective
State-of-the-Art Lectures / Educational Sessions (E)
Lecture series 1: Autoimmune Diseases
E 1 General aspects of Autoimmunity
E 2 Cardiovascular diseases
E 3 Multiple Sclerosis
E 4 Rheumatoid Arthritis
E 5 Diabetes
Lecture series 2: Immunology of Tropical Diseases
E 6 HIV
E 7 Malaria
E 8 Helminth and Nematode infections
E 9 Protozoal infections
E 10 Tuberculosis
생명공학중 핵심분야중 하나인 면역학중 innate immunity 및 백신분야의 분석을 신청합니다.
연세대 김수기
때: July 22 - 27, 2001 장소 : The 11th International Congress of Immunology will take place at Stockholm International Fairs, Sunday July 22 - Friday July 27, 2001.
Around 600 internationally renowned immunologists are invited as speakers
or chairpersons in approximately 64 Symposia (S), 127 Workshops (W), 11
Current Controversies (C) and 10 State-of-the-Art / Educational Sessions (E).
Symposia (S)
Theme 1 Generation and lifespan of immunocompetent cells
S 1.1 Haematopoietic stem cell emergence, expansion and differentiation
S 1.2 Stem cell biology and transplantation
S 1.3 Lymphoid organogenesis
S 1.4 Lymphoid malignancies
S 1.5 Transcriptional control of lymphocyte differentiation
S 1.6 Molecular mechanisms of gene recombination in the immune system
S 1.7 Development of the innate immune system
S 1.8 Signalling in lymphocytes
S 1.9 Lymphocyte development
S 1.10 Genomic analysis of the evolution of the immune system
S 1.11 Physiology of the immune system
S 1.12 Apoptosis and the immune system
S 1.13 Central tolerance
S 1.14 Primary Immunodeficiencies
Theme 2 Induction of adaptive immunity
S 2.1 Dendritic cells in immune induction and regulation
S 2.2 Antigen processing and presentation in the MHC class I pathway
S 2.3 Antigen processing and presentation in the MHC class II pathway
S 2.4 Fc receptors in acquired immunity
S 2.5 The T cell receptor
S 2.6 Induction of B cells in germinal centers
S 2.7 The immunological synapse
S 2.8 Costimulation in health and disease
S 2.9 Molecular interactions in infection and immunity
S 2.10 Induction of memory
S 2.11 Effector functions
Theme 3 Regulation of the immune response
S 3.1 Regulatory cells and their microenvironment
S 3.2 Regulatory chemokines in the immune response
S 3.3 Lymphocyte trafficking
S 3.4 Central immunological tolerance
S 3.5 Genetics and effector mechanisms of autoimmunity
S 3.6 Allergy
S 3.7 Immunological diseases and their treatment
S 3.8 Interaction between tumours and the immune system
S 3.9 Regulatory mechanisms in immunity
S 3.10 Regulation of autoimmunity
S 3.11 Gene targeting in the immune system
S 3.12 Peripheral immunological tolerance
Theme 4 Host-parasite interactions, innate immunity,
reproductive and local immunity
S 4.1 Receptor activation of innate immune responses
S 4.2 Peptides and proteins as effector molecules in innate immunity
S 4.3 Microbial evasion of innate immunity
S 4.4 Antimicrobial activities of the innate immune system
S 4.5 Chemokines and chemokine receptors
S 4.6 Reproductive immunology
S 4.7 Links between innate and adaptive immunity
S 4.8 Acute and chronic inflammation of the gastrointestinal tract
S 4.9 Gene regulation of acute inflammation
S 4.10 Antigen processing and presentation at mucosal surfaces
S 4.11 Complement activation and regulation
S 4.12 NK cells in health and disease
S 4.13 Host-parasite interactions
S 4.14 Mechanisms of tolerance induction at mucosal sites
S 4.15 Effector mechanisms at mucosal tissues
Theme 5 Immunotherapy/ vaccination and immunomodulation in
autoimmunity, allergy, cancer and infectious diseases
S 5.1 Components of the ideal vaccine strategy
S 5.2 Novel approaches to vaccination
S 5.3 Specific vaccination targets
S 5.4 Peptides as tools for the treatment of immunological diseases
S 5.5 Use of antibodies/fragments in the treatment of human disease
S 5.6 Use of cytokines, cytokine receptors, chemokines in the
treatment of human disease
S 5.7 Cell transplantation
S 5.8 Genetic manipulation, drugs and drug design in the treatment
of immunological disease
S 5.9 Cancer/tumour immunology
S 5.10 Apoptosis as an immunotherapeutic tool in the treatment
of human disease
S 5.11 Immunotherapy in allergy
S 5.12 Organ transplantation
Workshops (W)
Theme 1 Generation and lifespan of immunocompetent cells
W 1.1 Stem cell and lymphoid progenitor differentiation
W 1.2 Characterisation of haematopoietic stem cells
W 1.3 Culture and expansion of human stem cells
W 1.4 Transcriptional control of lymphocyte differentiation
W 1.5 Lymphoid organogenesis
W 1.6 Lymphocyte development and lineage commitment
W 1.7 Rearrangement of antigen receptor genes
W 1.8 The B cell antigen receptor complex
W 1.9 The T cell antigen receptor complex
W 1.10 Evolution of antigen receptor genes
W 1.11 Selection of T cell repertoires
W 1.12 Selection of B cell repertoires
W 1.13 Extra-thymic T cell differentiation
W 1.14 Lymphocyte homeostasis and lifespans
W 1.15 Signalling through B and T cell receptors
W 1.16 Microdomains (rafts) in signalling
W 1.17 Downstream signalling in lymphocytes
W 1.18 Molecular mechanisms of apoptosis
W 1.19 Apoptosis in the physiology of the immune system
W 1.20 Lymphoid malignancies
W 1.21 Primary lymphoid immunodeficiencies
W 1.22 Primary non-lymphoid immunodeficiencies
W 1.23 Gene therapy for haematopoietic disease
W 1.24 Ageing of the immune system
Theme 2 Induction of adaptive immunity
W 2.1 Antigen processing (MHC class I mediated)
W 2.2 Antigen processing (MHC class II mediated)
W 2.3 Trafficking and assembly of MHC molecules
W 2.4 Specificity and predictions of peptide-MHC interactions
W 2.5 Structure of MHC class I and class II molecules
W 2 6 Structure and function of non-classical MHC molecules
W 2.7 Origin and migration of dendritic cells
W 2.8 Dendritic cells in antigen presentation and immune induction
W 2.9 Induction and maturation of antigen presenting cells
W 2.10 Interaction between APC and T cells
W 2.11 Activation of different T helper cell subsets
W 2.12 Three dimensional structure of immunological
receptor-ligand interactions
W 2.13 Role of Fc-receptors in induction of immunity
W 2.14 Regulatory molecules in B cell activation
W 2.15 Regulation of immunoglobulin class switch
W 2.16 Signal transduction through cytokine and chemokine receptors
W 2.17 T-B cell collaboration
W 2.18 Cytokines and cytokine receptors
W 2.19 Chemokines and chemokine receptors
W 2.20 CD4 T cell effector functions
W 2.21 CD8 T cell effector functions
W 2.22 Antibody isotypes and effector functions
W 2.23 Mechanisms of memory induction and maintenance
W 2.24 Superantigen-mediated activation of T cells
W 2.25 MHC polymorphism and its biological significance
Theme 3 Regulation of the immune response
W 3.1 Chemokines and cellular movements
W 3.2 Chemokines in clinical medicine
W 3.3 Leukocyte-endothelial cell interactions
W 3.4 Cell trafficking within lymphoid organs
W 3.5 Central tolerance and repertoire selection
W 3.6 Peripheral tolerance and the role of the APC
W 3.7 Immunogenetics of autoimmune diseases
W 3.8 Experimental autoimmune diseases
W 3.9 Generation of the atopic state
W 3.10 Immunotherapy of allergies
W 3.11 Cytokines as mediators of immunological diseases
W 3.12 Tumour escape from the immune system
W 3.13 Immunity to tumours
W 3.14 Dominant immunological suppression
W 3.15 Regulatory helper lymphocytes
W 3.16 Interleukins and lymphocyte activation
W 3.17 Autoimmunity in endocrine organs
W 3.18 Autoimmunity in the joint
W 3.19 Autoimmunity in the central nervous system
W 3.20 Peripheral immunological tolerance of self-reactive T
lymphocytes
W 3.21 B lymphocyte anergy
W 3.22 Apoptosis in peripheral immunological tolerance
W 3.23 Immunosuppressive drugs
Theme 4 Host-parasite interactions, innate immunity,
reproductive and local immunity
W 4.1 Receptors of innate immune responses
W 4.2 Cytokine regulation of innate immune responses
W 4.3 Anti-microbial peptides
W 4.4 Evolution of innate immune responses
W 4.5 Interface between innate and adaptive immunity
W 4.6 The role of g/d T cells and other non-classical T cells
in immune responses
W 4.7 Complement and collectins in the innate immune defence
W 4.8 The role of NK and NKT cells in immune effector mechanisms
W 4.9 Microbial evasion of immune responses
W 4.10 Mechanisms of protection against intracellular microorganisms
W 4.11 Nitric oxide (NO) and oxygen radicals in immune effector
mechanisms
W 4.12 Complement-, Fc- and collectin receptors
W 4.13 Chemokines and chemokine receptors in inflammation
W 4.14 Reproductive immunology
W 4.15 Inflammation of the gastrointestinal tract
W 4.16 The intestinal microbial flora in health and disease
W 4.17 Inflammation in the respiratory tract
W 4.18 Allergies of skin and mucosa
W 4.19 Gene therapy in inflammatory disorders
W 4.20 Induction of mucosal immune responses
W 4.21 Immunological disorders of the skinW 4.22 The role of
lamina propria T cells in health and disease
W 4.23 Complement activation and regulation in health and disease
W 4.24 Cytokines in infectious diseases
W 4.25 Mucosal mast cells, basophils and eosinophils in health and disease
W 4.26 Tolerance induced by mucosal exposure to antigen
W 4.27 Inflammation of connective tissue and blood vessels
W 4.28 Function and structure of TNF and lymphotoxin and their receptors
Theme 5 Immunotherapy/ vaccination and immunomodulation in autoimmunity,
allergy, cancer and infectious diseases
W 5.1 Target identification for vaccination and immunotherapy
W 5.2 Specific vaccination targets
W 5.3 Peptides as tools in the treatment of immunological disease
W 5.4 Antibodies/fragments as tools for the treatment of diseases
W 5.5 Cytokines and chemokines in the treatment of disease
W 5.6 Cell and stem cell transplantation
W 5.7 Genetic manipulation, drugs and drug design
W 5.8 Immunological treatment of tumours
W 5.9 Apoptosis as an immunotherapeutic tool
W 5.10 Organ transplantation
W 5.11 Cardiovascular inflammation and disease
W 5.12 Inflammatory diseases of the nervous system
W 5.13 Immunological aspects of neurodegenerative diseases
W 5.14 Immuno-endocrinology
W 5.15 Neuroimmunology (psychoneuroimmunology)
W 5.16 Immunological mechanisms in the treatment of rheumatic diseases
W 5.17 Immunological disorders in renal disease
W 5.18 Granulocytes in inflammation
W 5.19 Immunology of HIV
W 5.20 Immunology of malaria infections
W 5.21 Viral infections and viral immunity
W 5.22 Immunology of intracellular pathogens
W 5.23 Immunology of extracellular pathogens
W 5.24 Immunotechnology
W 5.25 Immunity to pathogens of the developing world
W 5.26 Microarray technologies
W 5.27 Novel approaches to vaccination
Current Controversies (C)
C 1 Industrial funding of academic research is a threat to scientific freedom
C 2 Vaccination against HIV is an impossible dream
C 3 Oral tolerance will be a solution in allergy and autoimmunity
C 4 MHC polymorphism is a consequence of microbial pressure
C 5 Activation of T cell immunity requires specific recognition of non-self
C 6 Xenotransplantation is a solution to organ shortage
C 7 Autoimmunity is a normal consequence of adequate immune reactivity
C 8 Immunological memory requires persistence of antigen
C 9 Immunological cancer therapy will have to be individualised
C 10 Experimental models are of limited value to understand autoimmune
diseases in man
C 11 Antigen-based immunotherapy in allergy is ineffective
State-of-the-Art Lectures / Educational Sessions (E)
Lecture series 1: Autoimmune Diseases
E 1 General aspects of Autoimmunity
E 2 Cardiovascular diseases
E 3 Multiple Sclerosis
E 4 Rheumatoid Arthritis
E 5 Diabetes
Lecture series 2: Immunology of Tropical Diseases
E 6 HIV
E 7 Malaria
E 8 Helminth and Nematode infections
E 9 Protozoal infections
E 10 Tuberculosis
생명공학중 핵심분야중 하나인 면역학중 innate immunity 및 백신분야의 분석을 신청합니다.
연세대 김수기